Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1619-7089
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease ; day:2 ; month:2 ; year:2018 ; pages:1-10
European journal of nuclear medicine and molecular imaging ; (2.2.2018), 1-10

Schlagwort
Diagnose
Diagnostik
Differentialdiagnose
Pflegediagnose

Beteiligte Personen und Organisationen
Pascoal, Tharick A.
Mathotaarachchi, Sulantha
Shin, Monica
Park, Ah Yeon
Mohades, Sara
Benedet, Andrea L.
Kang, Min Su
Massarweh, Gassan
Soucy, Jean-Paul
Gauthier, Serge
Rosa-Neto, Pedro
SpringerLink (Online service)

DOI
10.1007/s00259-018-3933-3
URN
urn:nbn:de:1111-20180330411
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:54 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Pascoal, Tharick A.
  • Mathotaarachchi, Sulantha
  • Shin, Monica
  • Park, Ah Yeon
  • Mohades, Sara
  • Benedet, Andrea L.
  • Kang, Min Su
  • Massarweh, Gassan
  • Soucy, Jean-Paul
  • Gauthier, Serge
  • Rosa-Neto, Pedro
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease

APOE effects on regional tau in preclinical Alzheimer’s disease

APOE effects on regional tau in preclinical Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer’s disease: a longitudinal cohort study

Inter-network connectivity and amyloid-beta linked to cognitive decline in preclinical Alzheimer’s disease: a longitudinal cohort study

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer’s Disease Trial

Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer’s Disease Trial

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer’s Disease: The A4 Study

Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer’s Disease: The A4 Study

Verbundene Objekte